USA & Canada
Aspen Canada was founded in 2014 to support our products distributed in this region. The development of our complex API capabilities into niche FDF offerings represents an opportunity for future product launches in the United States. Our satellite API facility in Sioux City supports the Oss site in supplying APIs worldwide.
Contribution to Group revenue
Revenue contribution - by therapeutic category
- In the US, growth in total medicine spending net of rebates, discounts and other price concessions increased 4,5% to USD344 billion
- The volume of the United States prescription pharmaceutical market grew 2,7% in 2018
- Canada is the 10th largest pharmaceutical market with brand-name products accounting for 78% of sales
Source: December 2018 IQVIA and IQVIA Pharmafocus 2021
Number of products launched:
In-market sales value of pipeline as at 30 June 2019 anticipated to be launched in:
0 – 2 years
USD1 103 million
3 – 5 years
USD1 210 million
Number of product recalls:
Average staff turnover:
Number of work-related fatalities:
Number of permanent employees:
# The number of product launches has been restated to take into account discontinued operations.
|Sterile Focus Brands||355||329||2|
Note: Commercial Pharmaceuticals revenue is disclosed by customer geography.